Goldenseal (Hydrastis canadensis L.) Extracts Synergistically Enhance the Antibacterial Activity of Berberine via Efflux Pump Inhibition by Cech, Nadja B. & NC DOCKS at The University of North Carolina at Greensboro
Goldenseal (Hydrastis canadensis L.) Extracts Synergistically Enhance the Antibacterial 
Activity of Berberine via Efflux Pump Inhibition 
By: Keivan A. Ettefagh, Johnna T. Burns , Hiyas A. Junio, Glenn W. Kaatz, Nadja B. Cech 
Ettefagh, K. A., Burns, J. T., Junio, H. A., Kaatz, G. W., & Cech, N. B. (2010). Goldenseal 
(Hydrastis canadensis L.) extracts synergistically enhance the antibacterial activity of berberine 
via efflux pump inhibition.  Planta Medica, 77, 835-840. doi: 10.1055/s-0030-1250606 
Made available courtesy of Georg Thieme Verlag: http://dx.doi.org/10.1055/s-0030-1250606  
 
***© Georg Thieme Verlag. Reprinted with permission. No further reproduction is 
authorized without written permission from Georg Thieme Verlag. This version of the 
document is not the version of record. Figures and/or pictures may be missing from this 
format of the document. *** 
Abstract: 
Goldenseal (Hydrastis canadensis L.) is used to combat inflammation and infection. Its 
antibacterial activity in vitro has been attributed to its alkaloids, the most abundant of which is 
berberine. The goal of these studies was to compare the composition, antibacterial activity, and 
efflux pump inhibitory activity of ethanolic extracts prepared from roots and aerial portions of H. 
canadensis. Ethanolic extracts were prepared separately from roots and aerial portions of six H. 
canadensis plants. Extracts were analyzed for alkaloid concentration using LC‐MS and tested for 
antimicrobial activity against Staphylococcus aureus (NCTC 8325-4) and for inhibition of 
ethidium bromide efflux. Synergistic antibacterial activity was observed between the aerial 
extract (FIC 0.375) and to a lesser extent the root extract (FIC 0.750) and berberine. The aerial 
extract inhibited ethidium bromide efflux from wild-type S. aureus but had no effect on the 
expulsion of this compound from an isogenic derivative deleted fornorA. Our studies indicate 
that the roots of H. canadensis contain higher levels of alkaloids than the aerial portions, but the 
aerial portions synergize with berberine more significantly than the roots. Furthermore, extracts 
from the aerial portions of H. canadensis contain efflux pump inhibitors, while efflux pump 
inhibitory activity was not observed for the root extract. The three most abundant H. 
canadensis alkaloids, berberine, hydrastine, and canadine, are not responsible for the efflux 
pump inhibitory activity of the extracts from H. canadensis aerial portions. 





The rise in infections from multidrug resistant bacteria is recognized worldwide as a major health 
crisis. According to the European Antimicrobial Resistance Surveillance System, as many as 52 
million of the world population may carry multidrug resistant bacteria. One such resistant strain, 
methicillin-resistant Staphylococcus aureus (MRSA), is estimated to be responsible for over 
18000 annual deaths [1] in the US alone. Better methods to treat infections from resistant 
bacteria are needed. There is a long history of the use of botanical medicines to treat 
inflammation and infection. It is often argued that the inherent complexity of such preparations, 
which may lead to synergistic interactions, may make them more effective than their 
pharmaceutical counterparts [2, 3]. Furthermore, if such botanical medicines act through multiple 
different pathways, it may make the development of resistance more difficult. For these reasons, 
further research into the use of botanical medicines to combat bacterial infections is warranted. 
The botanical medicine goldenseal (Hydrastis canadensis L.) is the subject of this research. 
Goldenseal preparations are popular in the international market [4,5] and are among the top 20 
bestselling botanical dietary supplements in the US [6]. Crude extracts and isolated compounds 
from goldenseal have demonstrated antibacterial activity in vitro and in clinical trials [7–11]. The 
antibacterial activity of goldenseal has typically been attributed to alkaloids, especially berberine 
[11, 12], which has shown activity against various gram-positive bacteria, including MRSA [13]. 
However, there has been some suggestion that other compounds present in complex goldenseal 
preparations might enhance the antimicrobial activity of berberine [7, 14]. We have observed 
pronounced antimicrobial activity of extracts from the aerial portions of goldenseal, which could 
not be attributed to berberine alone. We hypothesize that these extracts contain efflux pump 
inhibitors that synergistically enhance the antimicrobial activity of berberine. Bacterial efflux 
pumps are membrane bound proteins that pump toxins out of bacterial cells [15]. Overexpression 
of efflux pumps contributes to the development of resistance in bacteria, including S. aureus 
[16]. Inhibition of efflux pumps may enhance the effectiveness of antimicrobial agents that are 
substrates for these pumps and decrease the minimum inhibitory concentration (MIC) for the 
antimicrobials [17]. 
The goals of these studies were (1) to compare alkaloid content in extracts prepared from below 
ground (roots and rhizomes) and above ground (leaves and stems) portions of H. canadensis, (2) 
to evaluate the antibacterial activity of H. canadensis extracts in combination with the 
antibacterial agent berberine, and (3) to determine whether H. canadensis extracts act as 
inhibitors of NorA, the major chromosomal S. aureus efflux pump. Ultimately, our objective was 
to show whether synergists other than the major known alkaloids are present in H. canadensis, 
and to determine which part of the plant would have higher levels of such synergists. These 
questions are important in the manufacture and quality control of dietary supplements from H. 
canadensis. More broadly, these studies are relevant because we demonstrate an analytical 
approach by which synergistic activity can be investigated prospectively in crude extracts of 
botanical medicines. 
Materials and Methods 
Cell lines, chemicals, and biochemicals 
Staphyloccus aureus NCTC 8325-4 [18] and its isogenic norA deletion mutant K1758 [19] were 
used. Mueller Hinton broth, carbonyl cyanide m-chloro-phenylhydrazone (CCCP, purity > 98% 
by TLC), berberine (purity > 98% by HPLC), (1R,9S)-(-)-β-hydrastine (purity > 98% by HPLC), 
and DMSO were purchased from Sigma Aldrich and canadine (tetrahydroberberine, purity > 
98% by HPLC, stereochemistry unconfirmed) was obtained from Sequoia Research. Acetic acid 
was purchased from Fisher Chemical. Ethanol (95%), HPLC grade acetonitrile, and HPLC grade 
methanol were obtained from Pharmaco-AAPER. Nanopure water was prepared with a 
nanodiamond water purification system from Barnstead. 
Plant material 
Hydrastis canadensis L. (Ranunculaceae) was cultivated in its native habitat (a hardwood forest 
in Hendersonville, NC, N 35° 24.277′,W082°20.993′, 702.4melevation) and harvested in 
September of 2008. A voucher specimen was deposited at the Herbarium of the University of 
North Carolina at Chapel Hill (NCU583414) and identified by Dr. Alan S. Weakly. Individual H. 
canadensis plants were harvested and numbered (Table 1).  
Extraction and LC‑MS  
The extracts (50% ethanol: 50% nanopure water) were prepared using 1 g of powdered leaves 
and stems or roots and rhizomes per 5 mL of solvent (1:5w:v) according to the standard 
procedures in the US dietary supplements industry [20]. Henceforth, the root and rhizome extract 
will be designated “root” and the leaf and stem extract will be designated “aerial”. Plant material 
was blended with solvent, macerated for 24 hr and filtered under vacuum. Extracts were stored in 
amber bottles at room temperature. Biological activity and HPLC profile were retained in these 
storage conditions for > 1 year. An entire below ground portion (roots and rhizome) and its 
corresponding aerial portions (leaves and stems) of six individual plants were extracted 
separately. The extracts were numbered so that in each case, the number for the root and aerial 
extract of a single plant matched. Two larger “pooled extracts” were also prepared, one using 
100 g of root/rhizomematerial and one using 100 g of aerial portions. All bioassay data presented 
herewere collected using these “pooled extracts”. Analysis of alkaloid content was accomplished 
with liquid chromatography–mass spectrometry (LC‑MS) using an ion trap mass spectrometer 
with electrospray source (LCQ Advantage; Thermo) coupled to reversed phase HPLC (HP1100; 
Agilent). A C-18 column (50mm× 2.1 mm, 3 μmparticle size, 110 Å pore size, Prevail packing; 
Grace and 0.5 μm precolumn filter; MacMod Analytical) was employed for the analysis of all 
extracts, using a 0.2mL/min flow rate and a 10 μL injection volume. The samples were analyzed 
using the following gradient, where A = 1% acetic acid in nanopurewater and B = HPLC grade 
acetonitrile: 100–68% A from 0 to 5 min; 68% − 0% A from 5 to 20min; 0% A from 20 to 25 
min, 100% B from 25–40 min. Mass spectrometric detection was conducted in the positive ion 
mode with a scan range of 50–2000 m/z. Capillary temperature was 275°C, sheath gas pressure 
was 20 (arbitrary units), and spray, capillary, and tube lens voltages were 4.5 kV, 3 V, and 60 V, 
respectively. 
Standards of the alkaloids berberine, hydrastine, and canadine were prepared at stock 
concentrations of 1mg/mL in methanol. Calibration curves over a concentration range of 0.05 to 
100 μM were plotted as peak area of the relevant selected ion trace versus concentration. 
Extracts were diluted as necessary in 50:50 ethanol: water to provide alkaloid concentrations 
within the linear range of the calibration curve. Alkaloidswere identified in the extracts by 
matching retention time and fragmentation patterns with the relevant standards. 
Table 1. Quantity of alkaloids in extracts from the root and rhizome or leaf and stem (aerial) 
portions of 6 individual H. canadensis plants and 2 “pooled samples”. Concentrations were 
calculated from calibration curves for standards of each alkaloid analyzed with LC‑MS in the 
positive ion mode. The “pooled root” and “pooled leaf” extracts were prepared from larger 
batches of plant material (including multiple individual plants) and used for antimicrobial 
testing. 
Extract  Berberine (mM)  Hydrastine (mM)  Canadine (mM) 
Root 1  29.9 ± 0.4  2.30 ± 0.04  0.069 ± 0.011 
Root 2  25.3 ± 0.5  2.08 ± 0.04  0.061 ± 0.010 
Root 3  39.6 ± 0.5  3.34 ± 0.06  0.078 ± 0.013 
Root 4  70.0 ± 0.9  5.23 ± 0.10  0.056 ± 0.009 
Root 5  25.0 ± 0.3  3.50 ± 0.07  0.074 ± 0.011 
Root 6  28.9 ± 0.4  2.42 ± 0.05  0.074 ± 0.012 
Average root  36.5 ± 0.5  3.15 ± 0.06  0.069 ± 0.011 
Aerial 1  8.5 ± 0.1  1.23 ± 0.02  0.042 ± 0.007 
Aerial 2  8.3 ± 0.1  1.58 ± 0.03  0.046 ± 0.007 
Aerial 3  8.8 ± 0.1  1.13 ± 0.02  0.029 ± 0.004 
Aerial 4  9.2 ± 0.1  0.77 ± 0.01  0.050 ± 0.008 
Aerial 5  6.2 ± 0.8  1.20 ± 0.02  0.059 ± 0.009 
Aerial 6  5.7 ± 0.1  0.83 ± 0.02  0.044 ± 0.007 
Average aerial  7.8 ± 0.1  1.12 ± 0.02  0.045 ± 0.007 
Pooled Sample root 16.6 ± 0.3  3.79 ± 0.07  0.069 ± 0.011 
Pooled Sample aerial 8.0 ± 0.1  2.61 ± 0.05  0.054 ± 0.008 
 
Fig. 1 Structures of major alkaloid constituents of Hydrastis canadensis, berberine (1), (1R,9S)-(-
)-β-hydrastine (2), and canadine (tetrahydroberberine) (3). 
Checkerboard assay with Staphyloccus aureus NCTC 8325-4 
Extracts were dried under nitrogen and redissolved in Mueller Hinton broth containing 10% 
DMSO and filtered through a 0.45 μm PVDF filter. Broth microdilution MIC assays were 
performed according to Clinical and Laboratory Standards Institute (CLSI) guidelines [21]. 
Extracts were standardized to berberine and tested in combination with berberine with a 
checkerboard assay [22] over a concentration range of 5 to 300 μg/mL (where these represent 
concentration of berberine either in the standard or the extract). A purified standard of berberine, 
which has well documented antimicrobial activity [23–25], served as the positive control. The 
assay was performed in triplicate in 96-well plates with 1 × 105 CFU/mL S. aureus, 2% final 
DMSO content, and a final well volume of 250 μL. The negative (vehicle) control consisted of 
2% DMSO in broth. MIC values were determined at the point at which there was no significant 
difference between OD600 of the vehicle control and the treatment. OD600 for wells containing 
only extracts or berberine (without bacteria) was subtracted from the relevant assay wells to 
minimize interference. FIC indices were calculated according to equation 1, where A and B are 
the compounds (or extracts) tested in combination, MICA is defined as the minimum inhibitory 
concentration of A alone, MICB is defined as the minimum inhibitory concentration of B alone, 
and [B] is defined as the MIC of B in the presence of a A, and [A] is defined as the MIC od A in 
the presence of B. 
 
(equation 1) 
Efflux pump assay 
Wild type S. aureus and its isogenic norA deletion mutant (NCTC 8325-4 and K1758, 
respectively) were grown in Mueller Hinton broth to OD600 = 0.740. Ethidium bromide and 
CCCP were added to final concentrations of 25 μM and 100 μM, respectively, and the solution 
was incubated at 20°C with agitation (300 RPM) for 20 min. This solution was diluted to OD600 
= 0.400 with fresh Mueller Hinton broth containing 10 μg/mL ethidium bromide and 100 μM 
CCCP. The solution was spun down in 1mL aliquots at 20°C for 5 min at 13000 × g in a 
Spectrafuge 24D centrifuge (Labnet). The supernatant was discarded and the red pellets placed 
on ice. At time of measurement, these pellets were thawed for 5 min and resuspended with 1mL 
fresh Mueller Hinton broth containing 2% DMSO with or without inhibitor. Fluorescence 
measurements were made using a Spex FluoroMax-2 spectro-fluorometer (Instruments S.A., 
Inc.) every second for 300 s, with λex = 530, λemiss = 600, and slit widths of 5 mm. 
Statistics 
Statistical significance of means versus control was evaluated using single factor ANOVA 
(calculated with Microsoft Excel version 2007) with p < 0.05 considered significant. 
Supporting information 
Chromatograms and CID fragmentation patterns for berberine, hydrastine, and canadine as well 
as data on inhibition of ethidium bromide efflux by the individual alkaloids are available as 
Supporting Information. 
Results 
The alkaloids berberine, hydrastine, and canadine (Fig. 1) were detected in all extracts, as 
confirmed based on matching retention times, molecular weights, and CID fragmentation 
patterns with standard compounds (Fig. 1S, Supporting Information). The configuration of 
hydrastine indicated in l” Fig. 1 is that reported for the standard, but the configuration of the 
canadine standard was not confirmed. The isolation of a ± mixture of canadine from H. 
canadensis has been previously reported [26], but it was not possible with the LC‑MS method 
employed to distinguish stereoisomers of hydrastine or canadine. 
Alkaloids were found in higher concentrations in root than in leaf extracts (l” Table 1). This was 
true for each of the individual root and leaf samples, and average values among the 6 root and 6 
aerial portion samples. For berberine, the root extracts contained an average of 5 times more 
berberine (36.45 ± 0.47mM in roots versus 7.77 ± 0.10mMin aerial portions, p = 0.002), 3 times 
more hydrastine (3.145 ± 0.058mM in roots versus 1.123 ± 0.021mM in aerial portions, p = 
0.002), and 1.5 times more canadine (0.069 ± 0.011mM in roots versus 0.045 ± 0.007 in aerial 
portions, p = 0.001) than did the aerial extracts. Consistent with previous reports [27], berberine 
was the most abundant of the alkaloids (an average of 6.12% in roots, 1.31% in aerial portions), 
followed by hydrastine (0.60% in roots, 0.22% in aerial portions) and, finally, canadine (0.11% 
in roots, 0.008% in aerial portions). 
As indicated by the FIC value of 0.375 (l” Table 2) and by the convex shape of the isobologram 
(l” Fig. 2), the extract prepared from a pooled sample of H. canadensis leaves synergistically 
enhanced the antimicrobial activity of berberine. A suggestion of synergistic enhancement by the 
root extract was observed as well (Fig. 2), but the results did not comply with the stringent 
guidelines of an FIC < 0.5 indicating synergy [28]. For validation purposes, berberine was tested 
in combination with itself (Fig. 2), and the effect was additive (FIC of 1.00, linear isobologram). 
The berberine standard also served as the positive control for the antimicrobial assays, and gave 
an MIC of 150 μg/mL, consistent with literature values [29–32]. 
Table 2 MIC and FIC indices of Hydrastis canadensis extracts or isolated alkaloids in 
combination with berberine. MIC indicates the minimum inhibitory concentration of the 
compound alone, while FIC (calculated with equation 1), indicates the degree of interaction 
between the given compound or extract and berberine. 
  MIC (μg/mL)  FIC Index 
Berberine  150  1.00 
Hydrastine  > 300  0 
Canadine  > 300  0 
Root extract  150  0.750 




Fig. 2 Isobolograms indicating inhibition of bacteria growth by H. canadensis extracts and added 
berberine. Berberine alone was also included in the assay for validation and to serve as a positive 
control. Extracts were dissolved in 2% DMSO in Mueller Hinton broth. Assays were performed 
in triplicate in a 96-well plate with 5x 105 CFU/mL S. aureus. 
 
 
Fig. 3 Percent fluorescence over time for S. aureus (NCTC 8325-4) loaded with ethidium 
bromide and treated with various extracts and controls. Treatments included the known efflux 
pump inhibitor CCCP (positive control) and extracts from the roots and aerial portions of H. 
canadensis. All extracts and CCCP were dissolved in Mueller Hinton broth containing 2% 
DMSO. Data points represent the average of three separate experiments (using 3 different pellets 
of S. aureus). Error bars are ± standard error. 
 
Fig. 4 Percent fluorescence over time for the norA-deleted S. aureus (K1758). Aside from the 
use of a different strain of bacteria, conditions were identical to those employed for Fig.3. 
The extract prepared from pooled aerial portions of H. canadensis was also shown to inhibit 
efflux of ethidium bromide from wild type S. aureus (Fig. 3), but not its norA-deleted derivative 
(Fig. 4). For wild-type S. aureus, the percent of ethidum bromide fluorescence after 3minutes 
compared to the initial reading for bacteria in broth alone was 66.7% ± 5.5% for the root extract 
(50 μg/mL), 79.2% ± 1.2% for the aerial extract (50 μg/mL), and 84.73% ± 1.29% for the 
positive control (CCCP at 20 μg/mL). The results for the CCCP and the aerial extract were 
significantly different from that of the negative control (ethidium bromide loaded bacteria in 
Mueller Hinton broth with 2% DMSO), with p values of 0.002 and 0.02, respectively. There was 
no significant difference in % fluorescence between the root extract and the negative control 
after 3 minutes. For the norA-deleted S. aureus, no significant inhibition of ethidium bromide 
efflux was observed for any of the treatments (H. canadensis aerial extract, H. canadensis root 
extract, or CCCP) after 3min (l” Fig. 4). 
Discussion 
Goldenseal roots (rather than aerial portions) are more commonly employed medicinally because 
of their higher alkaloid content [27]. Our results do show higher alkaloid content in the root 
extracts, but we show that when the extracts are standardized to berberine content, extracts from 
the aerial portions of the plants synergize the antimicrobial activity of berberine (l” Fig. 2). This 
finding indicates that some constituent(s) other than berberine in the extract from H. canadensis 
aerial portions synergistically enhance the antimicrobial activity of berberine. This synergistic 
enhancement is not due to hydrastine or canadine in the leaf extracts. Purified standards of these 
compounds exhibited no significant antimicrobial activity (MIC values of > 300 μg/mL, Table 
2), and did not enhance the antimicrobial activity of berberine (FIC = 0, l” Table 2). 
On the basis of literature reporting the presence of efflux pump inhibitors in berberine containing 
plants [33], we hypothesized that the synergists present in the extracts of H. canadensis aerial 
portions might act as inhibitors of the NorA efflux pump, the major  chromosomal efflux pump 
expressed by S. aureus. Indeed, our data (Figs. 3 and 4) show that extracts from H. canadensis 
aerial portions do contain NorA efflux pump inhibitors. Ethidium bromide is a known substrate 
of NorA and fluoresces strongly (due to intercalation with DNA) when inside bacterial cells [33]. 
With the ethidium bromide efflux assay, cells are loaded with ethidium bromide and 
fluorescence is monitored over time. A decrease in fluorescence indicates efflux of ethidium 
bromide from the cells, and in the presence of an efflux pump inhibitor, fluorescence should 
decrease more slowly. This effect is observed with CCCP, a known efflux pump inhibitor, and 
with the extract prepared from aerial portions of H. canadensis (Fig. 3). If inhibition of NorA is 
responsible for the altered behavior of wild type S. aureus in the presence of CCCP and H. 
canadensis extracts, no effect should be observed with a norA-deleted strain. This, indeed, was 
the case (Fig. 4). The efflux pump inhibitory activity observed was not due to the presence of 
berberine, hydrastine, or canadine, as evidenced by the fact that the root extract, which had 
higher alkaloid concentration, did not show activity in the assay (Fig. 3). To verify this, the 
alkaloids were each tested individually and showed no significant inhibition of ethidium bromide 
efflux (Fig. 2S, Supporting Information). 
Proponents of the use of botanical dietary supplements often argue that their complexity leads to 
enhanced efficacy due to synergistic interactions among multiple constituents. Here we 
demonstrate that extracts from the aerial portions of Hydrastis canadensis contain both the 
known antimicrobial agent berberine and other compounds (hitherto unidentified) that 
synergistically increase the antimicrobial activity of berberine. We also show that this 
enhancement of antimicrobial activity is likely to occur through inhibition of the NorA efflux 
pump. This finding is particularly interesting given that Hydrastis canadensis is listed as 
endangered by CITES in much of its native habitat. Our results show that the aerial portions of 
this plant, which can be harvested sustainably, are a good source of antibacterial compounds. 
Furthermore, we demonstrate that berberine is effective in vitro at lower dosages when used in 
the complex phytochemical matrix of the plant aerial portions than in the root portions. Follow- 
up studies to evaluate the toxicity of extracts prepared from roots versus aerial portions of H. 
canadensis and to test their antibacterial activity in vivo are warranted. 
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